In vivo disruption of latent HSV by designer endonuclease therapy

A large portion of the global population carries latent herpes simplex virus (HSV), which can periodically reactivate, resulting in asymptomatic shedding or formation of ulcerative lesions. Current anti-HSV drugs do not eliminate latent virus from sensory neurons where HSV resides, and therefore do...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCI Insight
Prif Awduron: Aubert, Martine, Madden, Emily A., Loprieno, Michelle, Feelixge, Harshana S. DeSilva, Stensland, Laurence, Huang, Meei-Li, Greninger, Alexander L., Roychoudhury, Pavitra, Niyonzima, Nixon, Nguyen, Thuy, Magaret, Amalia, Galleto, Roman, Stone, Daniel, Jerome, Keith R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2016
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5026126/
https://ncbi.nlm.nih.gov/pubmed/27642635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.88468
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg